EndGenitor might hold key to repairing blood vessels: Biomedical startup researchers grow cells from umbilical cord fluid
En d G e n i t o r Technologies Inc. is a prime example of the type of company BioCrossroads, central Indiana’s life sciences initiative, covets. Founded on the scientific discoveries of two Indiana University School of Medicine researchers, the venture is on the cusp of producing stem cells that someday could repair the blood vessels of heart attack victims and diabetics. Drs. Mervin Yoder, 52, and David Ingram, 39, company cofounders and professors at the Herman B Wells…